{
  "abstract": "Population approaches are an important component of reducing risk and disease burden",
  "authors": [
    {
      "affiliations": [
        "Cambridge Public Health, Department of Psychiatry, University of Cambridge, Cambridge, UK"
      ],
      "name": "Carol Brayne"
    },
    {
      "affiliations": [
        "Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands"
      ],
      "name": "Edo Richard"
    }
  ],
  "title": "Innovation in Alzheimer’s disease needs more than pharmaceutical solutions",
  "uid": "0c905682-532d-5fa4-94e7-510c9252244d"
}